EP0692965A4 - Method and composition for treatment of osteoporosis - Google Patents

Method and composition for treatment of osteoporosis

Info

Publication number
EP0692965A4
EP0692965A4 EP94913970A EP94913970A EP0692965A4 EP 0692965 A4 EP0692965 A4 EP 0692965A4 EP 94913970 A EP94913970 A EP 94913970A EP 94913970 A EP94913970 A EP 94913970A EP 0692965 A4 EP0692965 A4 EP 0692965A4
Authority
EP
European Patent Office
Prior art keywords
osteoporosis
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94913970A
Other languages
German (de)
French (fr)
Other versions
EP0692965A1 (en
Inventor
R Curtis Morris Jr
Anthony Sebastian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of EP0692965A1 publication Critical patent/EP0692965A1/en
Publication of EP0692965A4 publication Critical patent/EP0692965A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP94913970A 1993-04-02 1994-03-29 Method and composition for treatment of osteoporosis Withdrawn EP0692965A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4234993A 1993-04-02 1993-04-02
US42349 1993-04-02
PCT/US1994/003402 WO1994022457A1 (en) 1993-04-02 1994-03-29 Method and composition for treatment of osteoporosis

Publications (2)

Publication Number Publication Date
EP0692965A1 EP0692965A1 (en) 1996-01-24
EP0692965A4 true EP0692965A4 (en) 1998-08-12

Family

ID=21921399

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94913970A Withdrawn EP0692965A4 (en) 1993-04-02 1994-03-29 Method and composition for treatment of osteoporosis

Country Status (8)

Country Link
EP (1) EP0692965A4 (en)
JP (1) JPH08508502A (en)
KR (1) KR960701642A (en)
CN (1) CN1120314A (en)
AU (1) AU692155B2 (en)
BR (1) BR9406101A (en)
CA (1) CA2159354A1 (en)
WO (1) WO1994022457A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004524354A (en) * 2001-03-16 2004-08-12 ワイス Estrogen replacement therapy
EP1651246A4 (en) * 2003-08-06 2009-06-24 Innophos Inc Method for promoting bone growth
CN106132912B (en) * 2014-04-02 2018-05-11 国际壳牌研究有限公司 Method for separating monoethylene glycol and 1,2- butanediols

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608077A (en) * 1969-11-13 1971-09-21 Syntex Corp Stabilization of metal steroid alcohol sulfates
EP0220844A2 (en) * 1985-10-22 1987-05-06 University Of Florida Use of estrogen-dihydropyridine compounds for weight control
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078060A (en) * 1976-05-10 1978-03-07 Richardson-Merrell Inc. Method of inducing an estrogenic response
US4261985A (en) * 1978-11-22 1981-04-14 Ciba-Geigy Corporation Novel diuretics
US4814177A (en) * 1986-03-18 1989-03-21 Board Of Regents, University Of Texas System Ultradense and more soluble and bioavailable preparations of calcium citrate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608077A (en) * 1969-11-13 1971-09-21 Syntex Corp Stabilization of metal steroid alcohol sulfates
EP0220844A2 (en) * 1985-10-22 1987-05-06 University Of Florida Use of estrogen-dihydropyridine compounds for weight control
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9422457A1 *

Also Published As

Publication number Publication date
CA2159354A1 (en) 1994-10-13
AU692155B2 (en) 1998-06-04
AU6621994A (en) 1994-10-24
BR9406101A (en) 1995-12-19
CN1120314A (en) 1996-04-10
JPH08508502A (en) 1996-09-10
EP0692965A1 (en) 1996-01-24
WO1994022457A1 (en) 1994-10-13
KR960701642A (en) 1996-03-28

Similar Documents

Publication Publication Date Title
AP9300598A0 (en) Compositions and method for waste treatment
AU3984093A (en) Bone cement composition and method of manufacture
PL324970A1 (en) Method of and composition for treating asthma
EP0717592A4 (en) Method and composition for the treatment of apathy-amotivation syndrome
HU9502565D0 (en) Method of treating solid waste
HU9603607D0 (en) Method and prophylaxis of osteoporosis
IL104940A0 (en) Method and composition for the treatment of osteoporosis
IL116142A0 (en) Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
ZA948252B (en) Method and composition for treatment of autoimmune hepatitis
PL317197A1 (en) Compositions for and method of treating sclerosis multiplex
GB9014307D0 (en) Method of treatment and compositions therefor
GB9306380D0 (en) Method and apparatus for removal of bone cement and ostealprostheses
PL311268A1 (en) Cholestyramine containing composition and method of obtaining same
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
IL100750A0 (en) Method and apparatus particularly useful for treating osteoporosis
EP0692965A4 (en) Method and composition for treatment of osteoporosis
PL303822A1 (en) Therapeutic compositions containing ipsapyrone and method of obtaining them
GB9202196D0 (en) Method of treatment
AU7379296A (en) Method and composition for treatment of osteoporosis
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
HU9401479D0 (en) Method for treatment of molfen metals
SG66305A1 (en) Composition and method for treatment of phoshated surfaces
GB9201391D0 (en) Method of treatment
GB9301720D0 (en) Method and compositions for treating anoestrus
GB9307004D0 (en) Method of treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951011

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

AX Request for extension of the european patent

Free format text: SI PAYMENT 951011

RAX Requested extension states of the european patent have changed

Free format text: SI PAYMENT 951011

RHK1 Main classification (correction)

Ipc: A61K 31/565

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980919